Virta Health, a startup that is taking a software approach to treating diabetes rather than pills or injections, has raised $45 million in funding to support its technology.
San Francisco-based Virta says its software “reverses” diabetes through behavioral changes that reduce the biological measures of the disease. The company’s software platform, accessible via a mobile app, helps the patient track blood sugar, carbohydrate intake, and other indicators. The Virta starter kit includes a scale, blood pressure cuff, and glucose meter that automatically upload data to the Virta app. The platform also provides clinicians and caregivers real-time access to the data so that they can provide additional guidance and support.
Virta unveiled its technology last year, along with $37 million in funding. At that time, the startup pointed to published clinical data from a Virta-funded study showing that after 10 weeks, the software reduced or eliminated the need to take insulin in 87 percent of patients.